WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007000779) PHARMACEUTICAL SUSTAINED RELEASE COMPOSITIONS AND PROCESSES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/000779    International Application No.:    PCT/IN2006/000225
Publication Date: 04.01.2007 International Filing Date: 29.06.2006
Chapter 2 Demand Filed:    25.09.2015    
IPC:
A61K 9/20 (2006.01), A61K 9/16 (2006.01), A61K 31/522 (2006.01), A61P 31/12 (2006.01)
Applicants: PANACEA BIOTEC LTD. [IN/IN]; B-1 Extn./A-27, Mohan Co-operative Industrial Estate, Mathura Road, New Delhi 110 044 (IN) (For All Designated States Except US).
JAIN, Rajesh [IN/IN]; (IN) (For US Only).
JINDAL, Kour, Chand [IN/IN]; (IN) (For US Only).
SINGH, Sukhjeet [IN/IN]; (IN) (For US Only).
BOLDHANE, Sanjay [IN/IN]; (IN) (For US Only)
Inventors: JAIN, Rajesh; (IN).
JINDAL, Kour, Chand; (IN).
SINGH, Sukhjeet; (IN).
BOLDHANE, Sanjay; (IN)
Agent: GUPTA, Bhartee; Panacea Biotec Ltd. B-1 Extn./A-27 Mohan Co-operative Industrial Estate Mathura Road New Delhi 110 044 (IN)
Priority Data:
1680/DEL/2005 29.06.2005 IN
Title (EN) PHARMACEUTICAL SUSTAINED RELEASE COMPOSITIONS AND PROCESSES THEREOF
(FR) NOUVELLES COMPOSITIONS PHARMACEUTIQUES A LIBERATION PROLONGEE ET PROCEDES POUR LEUR PREPARATION
Abstract: front page image
(EN)Pharmaceutical sustained release composition comprising at least one active agent(s), or its tautomeric forms, analogues, isomers, polymorphs, solvates, or salts thereof; preferably an antiviral active agent is provided. Also provided is a process of preparation of such composition and method of using them. The sustained release compositions of the present invention are able to deliver the active agent in a desired manner for an extended period of time.
(FR)L'invention concerne une nouvelle composition pharmaceutique à libération prolongée comprenant au moins un agent actif, ou ses formes tautomères, des analogues, des isomères, des polymorphes, des solvates ou des sels de cet agent, lequel se présente de préférence sous la forme d'un agent antiviral actif. L'invention concerne également un procédé de préparation de cette composition et une méthode d'utilisation de celle-ci. Les compositions à libération prolongée de la présente invention permettent d'administrer l'agent actif comme on le souhaite pendant une durée prolongée.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)